从天然免疫介导的代谢性炎性反应角度探讨糖脂代谢病“浊”的生物学本质(7)
[49]Van Rooyen DM，Gan LT，Yeh MM，et al.Pharmacological cholesterol lowering reverses fibrotic NASH in obese，diabetic mice with metabolic syndrome[J].J Hepatol，2013，59(1)：144152.
[50]ZelberSagi S，Azar S，Nemirovski A，et al.Serum levels of endocannabinoids are independently associated with nonalcoholic fatty liver disease[J].Obesity(Silver Spring)，2017，25(1)：94101.
[51]Green CL，Mitchell SE，Derous D，et al.The effects of graded levels of calorie restriction：IX.Global metabolomic screen reveals modulation of carnitines，sphingolipids and bile acids in the liver of C57BL/6 mice[J].Aging Cell，2017，16(3)：529540.
[52]Vorkas PA，Shalhoub J，Isaac G，et al.Metabolic phenotyping of atherosclerotic plaques reveals latent associations between free cholesterol and ceramide metabolism in atherogenesis[J].J Proteome Res，2015，14(3)：13891399.
[53]Cheng JM，Suoniemi M，Kardys I，et al.Plasma concentrations of molecular lipid species in relation to coronary plaque characteristics and cardiovascular outcome：Results of the ATHEROREMOIVUS study[J].Atherosclerosis，2015，243(2)：560566.
[54]Park JY，Lee SH，Shin MJ，et al.Alteration in metabolic signature and lipid metabolism in patients with angina pectoris and myocardial infarction[J].PLoS One，2015，10(8)：e0135228.
[55]Vorkas PA，Shalhoub J，Lewis MR，et al.Metabolic phenotypes of carotid atherosclerotic plaques relate to stroke risk：an exploratory study[J].Eur J Vasc Endovasc Surg，2016，52(1)：510.
(2018-12-10收稿責任编辑：王明), 百拇医药(吴小琴 颜凯旋 杨勇 荣向路)
[50]ZelberSagi S，Azar S，Nemirovski A，et al.Serum levels of endocannabinoids are independently associated with nonalcoholic fatty liver disease[J].Obesity(Silver Spring)，2017，25(1)：94101.
[51]Green CL，Mitchell SE，Derous D，et al.The effects of graded levels of calorie restriction：IX.Global metabolomic screen reveals modulation of carnitines，sphingolipids and bile acids in the liver of C57BL/6 mice[J].Aging Cell，2017，16(3)：529540.
[52]Vorkas PA，Shalhoub J，Isaac G，et al.Metabolic phenotyping of atherosclerotic plaques reveals latent associations between free cholesterol and ceramide metabolism in atherogenesis[J].J Proteome Res，2015，14(3)：13891399.
[53]Cheng JM，Suoniemi M，Kardys I，et al.Plasma concentrations of molecular lipid species in relation to coronary plaque characteristics and cardiovascular outcome：Results of the ATHEROREMOIVUS study[J].Atherosclerosis，2015，243(2)：560566.
[54]Park JY，Lee SH，Shin MJ，et al.Alteration in metabolic signature and lipid metabolism in patients with angina pectoris and myocardial infarction[J].PLoS One，2015，10(8)：e0135228.
[55]Vorkas PA，Shalhoub J，Lewis MR，et al.Metabolic phenotypes of carotid atherosclerotic plaques relate to stroke risk：an exploratory study[J].Eur J Vasc Endovasc Surg，2016，52(1)：510.
(2018-12-10收稿責任编辑：王明), 百拇医药(吴小琴 颜凯旋 杨勇 荣向路)